Skip to main content
. 2013 Jun 18;109(1):249–256. doi: 10.1038/bjc.2013.292

Table 1. Study population and risk of detecting any colorectal pathology at colonoscopy following a positive stool test.

 
All patients
Colorectal pathology
Normal colonoscopy
 
Risk of colorectal pathology (multivariate analysis)
 
 
  n % n % n % P-value OR 95% CI P-value
 
4188
 
3043
 
1145
 
 
 
 
 
Age
55 877 21 565 19 312 27   1    
56–64 1280 31 925 30 355 31   1.41 1.17–1.71 <0.001
65
2031
49
1553
51
478
42
<0.001
1.89
1.58–2.27
<0.001
Sex
Male 2489 59 1990 65 499 44   1    
Female
1699
41
1053
35
646
56
<0.001
2.49
2.16–2.86
<0.001
Deprivation category
1 (most deprived) 1506 36 1060 35 446 39   1    
2 785 19 568 19 217 19   1.08 0.88–1.31 0.461
3 666 16 507 17 159 14   1.30 1.05–1.61 0.017
4 527 13 380 13 147 13   1.02 0.81–1.28 0.879
5 (least deprived)
699
17
525
17
174
15
0.017
1.21
0.98–1.49
0.080
Type of positive stool test
gFOBt 739 18 561 18 178 16   1    
FIT
3449
82
2482
82
967
84
0.029
1.20
0.99–1.45
0.062
Aspirin
No 3531 84 2592 85 939 82   1    
Yes
657
16
451
15
206
18
0.012
0.67
0.55–0.81
<0.001
Statin
 
 
 
 
 
 
 
 
 
 
No 3308 79 2422 80 886 77        
Yes
880
21
621
20
259
23
0.117
 
 
 
ACE inhibitor
 
 
 
 
 
 
 
 
 
 
No 3682 88 2672 88 1010 88        
Yes
506
12
371
12
165
12
0.722
 
 
 
1 Medications
 
 
 
 
 
 
 
 
 
 
No 3088 74 2271 75 817 71        
Yes 1100 26 772 25 328 29 0.032      

Abbreviations: ACE=angiotensin-converting enzyme; CI=confidence interval; FIT=faecal immunochemical test; gFOBt=guaiac-based faecal occult blood test; OR=odds ratio.